Francis Knuettel II - 15 Feb 2024 Form 3/A Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
CEO, Pres., CFO, Treas & Secty
Signature
/s/ Francis Knuettel II
Issuer symbol
CHRO
Transactions as of
15 Feb 2024
Net transactions value
$0
Form type
3/A
Filing time
02 Jul 2024, 17:15:45 UTC
Date Of Original Report
15 Feb 2024
Previous filing
08 Sep 2023
Next filing
23 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CHRO Common Stock 130,953 15 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were omitted from the reporting person's original Form 3, and also were omitted from two Forms 4 and one Form 4/A filed by the reporting person after his original Form 3 was filed.